CARM — Carisma Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Carisma Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	52.4	163	167	77.6	17.9
Net Total Accounts Receivable
Net Total Receivables	—	24.5	0.825	—	2.86
Prepaid Expenses
Total Other Current Assets
Total Current Assets	62.9	206	189	80.5	23.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.123	0.043	0	8.94	6.42
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	123	241	189	89.6	30.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18	11.6	31	15.9	16.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	132	69	31	63	58.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-9.23	172	158	26.5	-27.9
Total Liabilities & Shareholders' Equity	123	241	189	89.6	30.5
Total Common Shares Outstanding